Ashton D, Hieble P, Gout B, Aiyar N
SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, USA.
Pharmacology. 2000 Aug;61(2):101-5. doi: 10.1159/000028388.
Human adrenomedullin (AM) and human calcitonin gene-related peptide (CGRP) produced a concentration-dependent relaxation in mouse aorta, precontracted with noradrenaline. EC(50) values for AM and CGRP were 9.8 +/- 2.4 and 4.2 +/- 0.1 nmol/l, respectively. AM-mediated vasorelaxation was partially (3-fold) shifted by AM(22-52), the C-terminal AM fragment, but not by CGRP(8-37), a selective CGRP1 antagonist. Both AM(22-52) and CGRP(8-37) failed to inhibit CGRP-mediated vasorelaxation of mouse aorta rings. Binding of rat [(125)I]AM to these membranes was specific. Both human AM and AM(22-52) displaced rat [(125)I]AM binding in a concentration-dependent manner with IC(50) values of 12.0 +/- 4 and 19.4 +/- 8 nmol/l, respectively. In contrast, both human CGRP and CGRP(8-37) were weak in displacing [(125)I]AM binding. Very little specific binding was observed with [(125)I]CGRP. In conclusion, the data presented here demonstrate that the mouse aorta displays AM receptors that mediate vasorelaxation.
人肾上腺髓质素(AM)和人降钙素基因相关肽(CGRP)可使去甲肾上腺素预收缩的小鼠主动脉产生浓度依赖性舒张。AM和CGRP的半数有效浓度(EC50)值分别为9.8±2.4和4.2±0.1 nmol/L。AM介导的血管舒张被C端AM片段AM(22 - 52)部分(3倍)移位,但不被选择性CGRP1拮抗剂CGRP(8 - 37)移位。AM(22 - 52)和CGRP(8 - 37)均未能抑制CGRP介导的小鼠主动脉环血管舒张。大鼠[125I]AM与这些膜的结合具有特异性。人AM和AM(22 - 52)均以浓度依赖性方式取代大鼠[125I]AM的结合,IC50值分别为12.0±4和19.4±8 nmol/L。相比之下,人CGRP和CGRP(8 - 37)在取代[125I]AM结合方面作用较弱。用[125I]CGRP观察到的特异性结合很少。总之,此处给出的数据表明小鼠主动脉存在介导血管舒张的AM受体。